A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Neoplasm
Sponsor: Mayo Clinic